2023-03-30T16:58:22+08:00 weekly 1.0 https://ca.prisysbiotech.com/ 2024-11-11T19:09:02+08:00 weekly 0.9 https://ca.prisysbiotech.com/animal-welfare 2024-11-11T19:09:01+08:00 weekly 0.9 https://ca.prisysbiotech.com/translational-research-center 2024-11-11T19:09:19+08:00 weekly 0.9 https://ca.prisysbiotech.com/ophthalmic-disease-research 2024-11-11T19:09:04+08:00 weekly 0.9 https://ca.prisysbiotech.com/hematological-disease-research 2024-11-11T19:09:05+08:00 weekly 0.9 https://ca.prisysbiotech.com/respiratory-disease-research 2024-11-11T19:09:10+08:00 weekly 0.9 https://ca.prisysbiotech.com/metabolic-syndromes-research 2024-11-11T19:09:18+08:00 weekly 0.9 https://ca.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-11T19:09:09+08:00 weekly 0.9 https://ca.prisysbiotech.com/inflammation-immunology-disorders 2023-02-27T15:56:40+08:00 weekly 0.9 https://ca.prisysbiotech.com/co-develop 2026-08-09T03:15:42+08:00 weekly 0.9 https://ca.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://ca.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://ca.prisysbiotech.com/nephrology 2024-11-11T19:09:00+08:00 weekly 0.9 https://ca.prisysbiotech.com/about-us 2024-11-11T19:09:01+08:00 weekly 0.9 https://ca.prisysbiotech.com/contact-us 2023-04-01T14:47:07+08:00 weekly 0.9 https://ca.prisysbiotech.com/newslist-1 2024-11-11T19:09:01+08:00 weekly 0.9 https://ca.prisysbiotech.com/products 2023-04-01T14:46:55+08:00 weekly 0.9 https://ca.prisysbiotech.com/safety-evaluation/ 2023-04-01T14:46:55+08:00 weekly 1.0 https://ca.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T14:46:56+08:00 weekly 0.9 https://ca.prisysbiotech.com/pk-pd-adme/ 2023-04-01T14:46:56+08:00 weekly 0.9 https://ca.prisysbiotech.com/translation-research/ 2023-04-01T14:46:56+08:00 weekly 0.9 https://ca.prisysbiotech.com/biosafety-research/ 2024-04-10T04:17:33+08:00 weekly 0.9 https://ca.prisysbiotech.com/clearpoint/ 2026-08-13T18:35:42+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-11T19:09:03+08:00 weekly 0.8 https://ca.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-11T19:09:07+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-11T19:09:08+08:00 weekly 0.8 https://ca.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-11T19:08:57+08:00 weekly 0.8 https://ca.prisysbiotech.com/translation-research/nhpresources.html 2024-11-11T19:09:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-11T19:09:06+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/translation-research/translational-studies.html 2024-11-11T19:09:05+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-11T19:09:00+08:00 weekly 0.8 https://ca.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-11T19:09:03+08:00 weekly 0.8 https://ca.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-11T19:08:59+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-11T19:08:57+08:00 weekly 0.8 https://ca.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-11T19:36:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2026-08-13T18:36:04+08:00 weekly 0.8 https://ca.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-11T19:09:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-11T19:09:11+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-11T19:09:13+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-11T19:09:04+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-11T19:09:06+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-11T19:09:02+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-11T19:09:03+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-11T19:09:21+08:00 weekly 0.8 https://ca.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-11T19:09:14+08:00 weekly 0.8 https://ca.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-11T19:09:13+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-11T19:09:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-26T13:56:48+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-26T13:56:53+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-26T13:56:54+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-26T13:56:58+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-11-11T19:09:21+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-26T14:26:36+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-26T14:26:39+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-12-10T08:51:54+08:00 weekly 0.8 https://ca.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-13T06:56:48+08:00 weekly 0.8 https://ca.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-04-01T22:55:45+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-01T23:31:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-25T17:49:52+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-25T17:49:55+08:00 weekly 0.8 https://ca.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-26T05:57:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-16T08:27:22+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-23T00:24:31+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-10-01T07:58:05+08:00 weekly 0.8 https://ca.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-08T07:17:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T11:27:00+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T18:40:12+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-05-04T05:51:50+08:00 weekly 0.8 https://ca.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-05-04T05:51:50+08:00 weekly 0.8 https://ca.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-05-04T05:51:52+08:00 weekly 0.8 https://ca.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-04T06:19:51+08:00 weekly 0.8 https://ca.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-25T21:48:30+08:00 weekly 0.8 https://ca.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2026-05-25T21:48:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2023-04-01T14:46:54+08:00 weekly 0.9 https://ca.prisysbiotech.com/newslist-714540-1 2023-04-01T14:46:54+08:00 weekly 0.9 https://ca.prisysbiotech.com/newslist-714541-1 2024-07-29T16:23:37+08:00 weekly 0.9 https://ca.prisysbiotech.com/newslist-818672-1 2026-05-04T05:51:56+08:00 weekly 0.9 https://ca.prisysbiotech.com/newslist-17857843854713856-1 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/meetprisys-sot2023-66148659.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-sot2023-66148660.html 2026-09-01T22:18:31+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66148661.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66148662.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66148663.html 2026-09-01T22:18:29+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/gene-therapy-nhp-model-66148664.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66148665.html 2026-09-01T22:18:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66148666.html 2026-09-01T22:18:30+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66148667.html 2026-09-01T22:18:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66148668.html 2026-09-01T22:18:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/gene-therapy-toxicology-66279703.html 2026-09-01T22:18:36+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67576830.html 2026-09-01T22:18:35+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67576831.html 2026-09-01T22:18:27+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67577694.html 2026-09-01T22:18:27+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67578421.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67579579.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/world-parkinsons-disease-day-67581566.html 2026-09-01T22:18:35+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67587952.html 2026-09-01T22:18:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67598057.html 2026-09-01T22:18:36+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68135787.html 2026-09-01T22:10:58+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68135788.html 2026-09-01T22:18:36+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68135789.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68135790.html 2026-09-01T22:10:58+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68338298.html 2026-09-01T22:11:04+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69060503.html 2026-09-01T22:11:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69065722.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69072054.html 2026-09-01T22:11:00+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69073358.html 2026-09-01T22:11:02+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69075680.html 2026-09-01T22:11:02+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69079908.html 2026-09-01T22:11:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309266.html 2026-09-01T22:18:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309306.html 2026-09-01T22:18:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309307.html 2026-09-01T22:11:03+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309387.html 2023-08-02T03:45:50+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69671733.html 2026-07-22T17:06:11+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69671735.html 2026-09-01T22:11:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71033873.html 2026-09-01T22:11:06+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71033930.html 2026-09-01T22:11:02+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/0-71033971.html 2026-09-01T22:04:07+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71033975.html 2026-09-01T22:11:00+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71034029.html 2026-09-01T22:11:05+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71034076.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72338640.html 2026-09-01T22:11:15+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72338641.html 2026-09-01T22:11:15+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72338643.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72338644.html 2026-09-01T22:11:10+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72338645.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72719586.html 2026-09-01T22:18:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73037396.html 2026-09-01T22:18:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73857252.html 2026-09-01T22:18:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73857893.html 2026-07-22T17:06:12+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74231533.html 2026-09-01T22:18:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74715452.html 2026-09-01T22:18:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74825638.html 2026-09-01T22:11:14+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75180874.html 2026-09-01T22:11:11+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75180875.html 2026-09-01T22:18:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76271360.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77130738.html 2026-09-01T22:11:16+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-78082048.html 2024-11-11T19:08:58+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-78082053.html 2026-09-01T22:11:14+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79185520.html 2026-09-01T22:04:12+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79185522.html 2026-09-01T22:11:22+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79185523.html 2026-09-01T22:11:15+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-asthma-model-79185524.html 2026-09-01T22:11:14+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79186859.html 2024-11-11T19:08:55+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410521.html 2026-09-01T22:11:20+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410522.html 2026-09-01T22:11:18+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410523.html 2026-09-01T22:11:20+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79526596.html 2026-09-01T22:11:16+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79526603.html 2026-09-01T22:11:18+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79526604.html 2026-09-01T22:18:30+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pk-strategies-of-pdc-79526605.html 2026-09-01T22:11:31+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79526606.html 2026-09-01T22:11:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526608.html 2026-09-01T22:11:22+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79526609.html 2026-09-01T22:11:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79526610.html 2026-09-01T22:11:22+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79526611.html 2026-09-01T22:18:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79526612.html 2026-09-01T22:11:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79526613.html 2026-09-01T22:11:21+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79526614.html 2026-09-01T22:11:20+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526615.html 2026-09-01T22:18:35+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79526616.html 2026-09-01T22:11:27+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79526618.html 2026-09-01T22:11:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79526619.html 2026-09-01T22:11:20+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79526620.html 2026-09-01T22:11:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79526621.html 2026-09-01T22:11:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79526623.html 2026-09-01T22:11:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79526624.html 2026-09-01T22:11:31+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79526625.html 2026-09-01T22:11:28+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79526626.html 2026-09-01T22:11:31+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79526627.html 2026-09-01T22:18:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79526628.html 2026-09-01T22:18:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79526629.html 2026-09-01T22:11:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79526631.html 2026-09-01T22:11:27+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79526632.html 2026-09-01T22:04:20+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79526633.html 2026-09-01T22:11:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79526634.html 2026-09-01T22:11:30+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79526636.html 2026-09-01T22:11:27+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79526637.html 2026-09-01T22:18:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79526638.html 2026-09-01T22:11:25+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79526639.html 2026-09-01T22:11:25+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79526640.html 2026-09-01T22:18:39+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/mrna-based-therapies-past-79526641.html 2026-09-01T22:18:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79526642.html 2026-09-01T22:11:19+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79526643.html 2026-09-01T22:11:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/mrna-based-therapies-present-79526644.html 2026-09-01T22:18:36+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79526645.html 2026-09-01T22:11:36+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79526646.html 2026-09-01T22:18:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79526647.html 2026-09-01T22:18:35+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79526648.html 2026-09-01T22:11:31+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79526649.html 2026-09-01T22:18:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79526650.html 2026-09-01T22:11:25+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/significance-principles-and-requirements-of-79526653.html 2026-09-01T22:11:18+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79527697.html 2026-09-01T22:18:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79527700.html 2026-09-01T22:11:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656473.html 2026-09-01T22:18:38+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120281.html 2026-09-01T22:11:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120282.html 2026-09-01T22:11:36+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120284.html 2026-09-01T22:11:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/convection-enhanced-delivery-81120285.html 2026-09-01T22:11:39+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120286.html 2026-09-01T22:11:35+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/human-disease-animal-models-81120287.html 2026-09-01T22:11:36+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120288.html 2026-09-01T22:11:37+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120289.html 2026-09-01T22:11:35+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120290.html 2026-09-01T22:11:35+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/china-experimental-monkey-industry-81120292.html 2026-09-01T22:11:39+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/compartment-pk-model-81120293.html 2026-09-01T22:11:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/animal-models-of-human-diseases-81120751.html 2026-09-01T22:11:41+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120752.html 2026-09-01T22:11:44+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82322110.html 2026-09-01T22:11:43+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82767570.html 2026-09-01T22:11:44+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82767573.html 2026-09-01T22:11:50+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82767574.html 2026-09-01T22:11:50+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82767575.html 2026-09-01T22:11:39+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82767576.html 2026-09-01T22:11:42+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82767577.html 2026-09-01T22:11:50+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82767581.html 2026-09-01T22:11:41+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82767584.html 2026-09-01T22:11:51+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82767591.html 2026-09-01T22:11:49+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83101643.html 2026-09-01T22:11:57+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83101651.html 2026-09-01T22:11:47+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83102707.html 2026-09-01T22:12:04+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83993440.html 2026-09-01T22:12:04+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83993441.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83993443.html 2026-09-01T22:11:54+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83993450.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83993451.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83993457.html 2026-09-01T22:12:04+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83993460.html 2026-09-01T22:12:02+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83993461.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83993985.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243636640261120.html 2026-09-01T22:12:24+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243637063148544.html 2026-09-01T22:12:25+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295463753229312.html 2026-09-01T22:18:02+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/animal-models-for-womens-health-17295463775462400.html 2026-07-22T17:46:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295463808902144.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295463865459712.html 2026-09-01T22:12:12+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295463919887360.html 2026-07-22T17:07:07+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/membranous-nephropathy-model-17295463939515392.html 2026-07-22T17:07:13+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295464097850368.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295464115381248.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295464179622912.html 2026-09-01T22:18:02+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295464190239744.html 2026-09-01T22:12:47+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295464235623424.html 2026-09-01T22:13:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295464272192512.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295464285611008.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295498806928384.html 2026-09-01T22:18:06+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295498813547520.html 2026-07-22T17:08:00+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295536708150272.html 2026-07-22T17:08:37+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299040456041472.html 2026-07-22T17:46:16+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374217460491264.html 2026-09-01T22:18:15+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374217483281408.html 2026-09-01T22:18:07+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374217486148608.html 2026-07-22T17:29:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374217490932736.html 2026-09-01T22:18:15+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374217520456704.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374217533727744.html 2026-07-22T17:46:15+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374217546163200.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374217677906944.html 2026-07-22T17:46:43+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374217679201280.html 2026-07-22T17:46:41+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374217766872064.html 2026-07-22T17:46:11+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374217893864448.html 2026-07-22T17:46:52+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374218250920960.html 2026-07-22T17:46:16+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17457947742528512.html 2026-09-01T22:18:14+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17457947768415232.html 2026-07-22T17:46:25+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17457947811013632.html 2025-07-25T17:49:54+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17457947811472384.html 2026-09-01T22:18:16+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17457947831198720.html 2025-07-25T17:49:59+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17457947865228288.html 2025-07-25T17:50:03+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17457947871454208.html 2026-07-22T17:46:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/key-considerations-for-dosing-volume-17457947900470272.html 2026-07-22T17:46:16+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17457948064228352.html 2026-09-01T22:18:27+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17457948086363136.html 2025-07-25T17:50:00+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17457948170986496.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17457963589493760.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17502552613610496.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17502552725939200.html 2026-09-01T22:18:20+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17502552734852096.html 2026-09-01T22:18:14+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17502552750629888.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17502552775910400.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-copd-model-17502553073214464.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/the-importance-of-administration-volume-17532427398669312.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/brain-targeted-drug-delivery-17532427406599168.html 2026-07-22T17:46:39+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17532427447755776.html 2026-09-01T22:18:22+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17532427469513728.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17532427470808064.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17532427589329920.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17532427722712064.html 2026-09-01T22:18:21+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17541900629337088.html 2025-10-08T07:17:19+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17563486407697408.html 2026-09-01T22:18:24+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17664203544421376.html 2025-12-18T10:43:10+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17664203559576576.html 2026-07-22T17:46:24+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17664203603698688.html 2026-09-01T22:18:24+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17664203610956800.html 2026-09-01T22:18:21+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17664203667170304.html 2025-12-18T10:43:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17664203678884864.html 2025-12-18T10:43:22+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17664203700085760.html 2025-12-18T10:43:18+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/rfp-template-for-nhp-studies-17664203744125952.html 2025-12-18T10:43:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17664203847148544.html 2026-07-22T17:29:42+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-renal-biopsy-17664203862074368.html 2026-09-01T22:18:25+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17664209744847872.html 2025-12-25T11:44:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674165941101568.html 2025-12-25T11:44:19+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674166061278208.html 2025-12-25T11:44:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674166083855360.html 2025-12-25T11:44:00+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674166152127488.html 2026-07-22T17:46:52+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674166251856896.html 2025-12-25T11:44:03+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674166332662784.html 2026-09-01T22:18:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674166410503168.html 2025-12-25T11:44:03+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674166519718912.html 2026-07-22T17:46:44+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674166642107392.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724115645539328.html 2026-01-29T18:40:20+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724115655042048.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724115708404736.html 2026-01-29T18:40:10+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724115708961792.html 2026-01-29T18:40:07+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724115710043136.html 2026-01-29T18:40:11+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724115743302656.html 2026-01-29T18:40:19+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724115823453184.html 2026-01-29T18:40:16+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724115902751744.html 2026-01-29T18:40:25+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724116068131840.html 2026-01-29T18:40:22+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724116461085696.html 2026-05-04T05:51:59+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17857844137862144.html 2026-05-04T05:51:56+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17857844173628416.html 2026-05-04T05:52:17+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17857844229841920.html 2026-05-04T05:52:09+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17857844242588672.html 2026-05-04T05:51:56+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17857844296377344.html 2026-05-04T05:52:11+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17857844366550016.html 2026-05-04T05:51:59+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17857844429480960.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/evaluating-dmpk-properties-17857844485022720.html 2026-05-04T05:52:01+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17857844709565440.html 2026-05-04T05:52:19+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17857844710319104.html 2026-05-04T05:52:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17857844721411072.html 2026-05-04T05:53:12+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17857845235295232.html 2026-05-04T05:53:21+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17857845236081664.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17857857078633472.html 2026-09-10T15:42:26+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17857857618551808.html 2026-05-04T06:19:14+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17857871207474176.html 2026-05-25T21:48:23+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-models-translational-drug-development-17888512921035776.html 2026-07-22T21:06:38+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888513036493824.html 2026-07-22T21:46:20+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888513062626304.html 2026-05-25T21:48:46+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888513343480832.html 2026-05-25T21:48:37+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888514071684096.html 2026-07-22T21:06:40+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-heart-failure-model-17950620000281600.html 2026-07-22T21:06:57+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17950620040619008.html 2026-07-22T20:48:49+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17950620121080832.html 2026-07-22T21:06:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17950620123505664.html 2026-07-22T21:06:30+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17950620144247808.html 2026-07-22T21:07:04+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17950620148933632.html 2026-07-22T20:49:10+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17950620193268736.html 2026-07-22T21:06:55+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17950620243731456.html 2026-07-22T17:46:24+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17950620318082048.html 2026-07-22T17:46:29+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17970373552137216.html 2026-07-22T17:46:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17970373556642816.html 2026-07-22T17:46:24+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17970373709554688.html 2026-07-22T17:46:31+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17970373759804416.html 2026-08-23T13:53:45+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/webinar-nhp-behavioratlas-17978550013862912.html 2026-07-28T12:21:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17978550016500736.html 2026-07-28T12:21:32+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17978550036276224.html 2026-07-28T12:21:44+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17978550097142784.html 2026-07-28T12:21:33+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17978550130287616.html 2026-07-28T12:21:50+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17978550462358528.html 2026-07-28T12:21:49+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17978550589596672.html 2026-08-03T08:08:08+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/behavior-in-rhesus-17986803414656000.html 2026-08-03T08:08:02+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17986803504800768.html 2026-08-05T22:31:43+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990481380975616.html 2026-09-01T22:18:21+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993353522865152.html 2026-09-01T22:18:35+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003293697090560.html 2026-09-01T22:18:45+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003293807076352.html 2026-09-01T22:18:44+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015460359513088.html 2026-08-23T15:37:34+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015554473845760.html 2026-09-01T22:18:47+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021155917194240.html 2026-09-01T12:05:50+08:00 weekly 0.8 https://ca.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028084761420800.html